Cargando…

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer

SIMPLE SUMMARY: Patients with triple-negative breast cancer (TNBC) respond well to chemotherapy initially but are prone to relapse. Searching for new therapeutic targets, we found that PRMT1 is highly expressed in TNBC tumor samples and is essential for breast cancer cell survival. Furthermore, this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suresh, Samyuktha, Huard, Solène, Brisson, Amélie, Némati, Fariba, Dakroub, Rayan, Poulard, Coralie, Ye, Mengliang, Martel, Elise, Reyes, Cécile, Silvestre, David C., Meseure, Didier, Nicolas, André, Gentien, David, Fayyad-Kazan, Hussein, Le Romancer, Muriel, Decaudin, Didier, Roman-Roman, Sergio, Dubois, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774276/ https://www.ncbi.nlm.nih.gov/pubmed/35053470 http://dx.doi.org/10.3390/cancers14020306

Ejemplares similares

Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
por: Dakroub, Rayan, et al.
Publicado: (2023)

Expression, Localization and Prognosis Association of MEP50 in Breast Cancer
por: Suresh, Samyuktha, et al.
Publicado: (2022)

PRMT5 prognostic value in cancer
por: Lattouf, Hanine, et al.
Publicado: (2019)

Structure, Activity, and Function of PRMT1
por: Thiebaut, Charlène, et al.
Publicado: (2021)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
por: Malbeteau, Lucie, et al.
Publicado: (2020)

PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
por: Malbeteau, Lucie, et al.
Publicado: (2022)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
por: Maubant, Sylvie, et al.
Publicado: (2018)

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
por: Amirouchene-Angelozzi, Nabil, et al.
Publicado: (2016)

PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
por: de Koning, Leanne, et al.
Publicado: (2019)

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
por: Nemati, Fariba, et al.
Publicado: (2023)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα (+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023)

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2023)

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages
por: Bougherara, Houcine, et al.
Publicado: (2017)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC
por: Montaudon, Elodie, et al.
Publicado: (2021)

Protein arginine methylation/demethylation and cancer
por: Poulard, Coralie, et al.
Publicado: (2016)

Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
por: Stimmer, Lev, et al.
Publicado: (2014)

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings
por: Bieche, Ivan, et al.
Publicado: (2014)

Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
por: Mery, Benoîte, et al.
Publicado: (2021)

Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a
por: Poulard, Coralie, et al.
Publicado: (2021)

In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts
por: Passeri, Thibault, et al.
Publicado: (2022)

JMJD6 Regulates ERα Methylation on Arginine
por: Poulard, Coralie, et al.
Publicado: (2014)

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
por: Choucair, Ali, et al.
Publicado: (2019)

Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target
por: Groenewoud, Arwin, et al.
Publicado: (2023)

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft
por: Passeri, Thibault, et al.
Publicado: (2022)

In Vitro Influence of Prophylaxis Cleaning on Enamel Remineralization with Casein Phosphopeptide-Amorphous Calcium Phosphate
por: Zeitouny, Mona, et al.
Publicado: (2020)

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
por: Montaudon, Elodie, et al.
Publicado: (2020)

Selumetinib-based therapy in uveal melanoma patient-derived xenografts
por: Decaudin, Didier, et al.
Publicado: (2018)

FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
por: Tarin, Malcy, et al.
Publicado: (2023)

Identification and Evaluation of New Immunoregulatory Genes in Mesenchymal Stromal Cells of Different Origins: Comparison of Normal and Inflammatory Conditions
por: Fayyad-Kazan, Mohammad, et al.
Publicado: (2017)

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
por: Carita, Guillaume, et al.
Publicado: (2016)

Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2021)

Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers
por: Nasrallah, A., et al.
Publicado: (2021)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2017)

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells
por: Najar, Mehdi, et al.
Publicado: (2016)

Relationship Between the Remaining Dentin Thickness and Coronal Pulp Status of Decayed Primary Molars
por: Berbari, Roula, et al.
Publicado: (2017)

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
por: Zajac, Olivier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0fcjujuuoj6h0eij3g3j6j96f8